Publication | Closed Access
Progressive Multifocal Leukoencephalopathy in a Patient on Ocrelizumab Monotherapy (4875)
11
Citations
0
References
2020
Year
Neurological DisorderHematologyClinical NeurologyPathologyProgressive Multiple SclerosisNeurologyProgressive Multifocal LeukoencephalopathyMultiple SclerosisNeuropathologyMedicineOcrelizumab MonotherapyNeuroimmunology
To report a case of progressive multifocal leukoencephalopathy (PML) occurring after two years of ocrelizumab monotherapy in a patient with progressive multiple sclerosis (MS) without prior immunomodulatory medication.